Mr. Ron Nagar reports

TEMPRAMED EXPANDS STRATEGIC PARTNERSHIP WITH MCKESSON MEDICAL-SURGICAL TO ACCELERATE NORTH AMERICAN GROWTH AND LAUNCH FULL PORTFOLIO ACROSS B2B CHANNELS

Tempramed Technologies Ltd. has expanded its relationship with McKesson Medical-Surgical (MMS). The agreement, dated June 23, 2026, broadens the scope of collaboration to include full portfolio distribution across North America, enhanced B2B (business-to-business) capabilities and deeper integration into one of the largest health care marketplaces in the United States.

Highlights of the partnership:

• Full portfolio distribution: inclusion of all Tempramed products, including VIVI Cap, VIVI Cap Smart, VIVI Epi and VIVI Med, across the MMS sales and distribution network;
• Expanded B2B reach: access to a broad network of healthcare providers, including physician offices, ambulatory surgery centres, long-term care facilities and home health organizations;
• Multichannel commercialization: distribution through Simply Medical LLC (a MMS affiliate), B2B2C (business-to-business-to-consumer) partners and leading platforms such as Optum Now;
• Scalable market access: integration into McKesson Medical-Surgical's marketplace, which aggregates approximately 270,000 SKUs (stock-keeping unitis) and serves a nationwide customer base.

McKesson Medical-Surgical is one of the largest and most established B2B health care distributors in North America, providing Tempramed with immediate access to a highly diversified and recurring customer base across non-acute care settings. This partnership marks a significant step in Tempramed's transition toward a more diversified revenue model, complementing its growing retail pharmacy footprint with scalable B2B distribution channels.

The inclusion of Tempramed's full product portfolio across McKesson Medical-Surgical's sales and distribution network is expected to enhance product visibility, streamline procurement for health care providers and accelerate adoption of the company's proprietary thermal protection solutions across multiple care settings.

Ron Nagar, chief executive officer of Tempramed, commented: "Our relationship with McKesson Medical-Surgical represents an important step in advancing our North American commercial strategy. Through this distribution arrangement, Tempramed expects to improve access to its temperature management solutions across a broader range of non-acute care providers and health care channels.

"By making our full portfolio available through McKesson Medical-Surgical's distribution network, we aim to simplify product availability for health care professionals and patients managing temperature-sensitive medications. We believe this expanded reach will support broader market awareness and facilitate future commercial growth.

"We continue to focus on building strategic distribution relationships that enhance market access and support the long-term adoption of our medication temperature management solutions."

This non-exclusive agreement reinforces Tempramed's positioning within the United States health care supply chain and aligns with broader industry trends toward decentralized care delivery, where a growing proportion of treatments are administered outside of traditional hospital settings. By leveraging McKesson Medical-Surgical's extensive infrastructure and customer network, Tempramed is well positioned to capture increasing demand for reliable, patient-centric solutions that protect the integrity of temperature-sensitive medications.

About Tempramed Technologies Ltd.

Tempramed Technologies Is a global medical device company with a portfolio of innovative, temperature-controlled medication storage solutions. Founded with the mission to safeguard the effectiveness of life-saving medications, Tempramed develops patented, Food and Drug Administration-registered, thermal insulation devices that work 24/seven without batteries or external power. With a product line already in market including VIVI Cap, VIVI Cap Smart, VIVI Epi and VIVI Med, Tempramed enables patients and health care providers to confidently manage temperature-sensitive medications anywhere, anytime. With operations in North America, Europe and Asia, Tempramed will continue to expand globally offering a solution for medication protection and adherence.

We seek Safe Harbor.